Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
Authors
Keywords
T cells, Cancer treatment, Cytotoxic T cells, Immune response, Cytokines, Lung and intrathoracic tumors, Metastatic tumors, Secondary lung tumors
Journal
PLoS One
Volume 8, Issue 7, Pages e69073
Publisher
Public Library of Science (PLoS)
Online
2013-07-24
DOI
10.1371/journal.pone.0069073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma
- (2012) K. N. Kodumudi et al. JOURNAL OF IMMUNOLOGY
- Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2--Tumor and Immunological Responses
- (2012) S. K. Seung et al. Science Translational Medicine
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
- (2011) Jeremy D. Waight et al. PLoS One
- Spontaneous Regression of Multiple Pulmonary Metastases After Radiofrequency Ablation of a Single Metastasis
- (2010) Pramod Rao et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation
- (2010) Melanie Widenmeyer et al. INTERNATIONAL JOURNAL OF CANCER
- IRAK-M Removal Counteracts Dendritic Cell Vaccine Deficits in Migration and Longevity
- (2010) M. E. Turnis et al. JOURNAL OF IMMUNOLOGY
- Immunogenic cell death modalities and their impact on cancer treatment
- (2009) Oliver Kepp et al. APOPTOSIS
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Abrogation of Local Cancer Recurrence After Radiofrequency Ablation by Dendritic Cell-based Hyperthermic Tumor Vaccine
- (2009) Qiong Liu et al. MOLECULAR THERAPY
- Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
- (2008) Mehran Habibi et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytokine expression profile over time in burned mice
- (2008) Celeste C. Finnerty et al. CYTOKINE
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
- (2008) A. P. Castano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scalable Routes to Gold Nanoshells with Tunable Sizes and Response to Near-Infrared Pulsed-Laser Irradiation
- (2008) Brian G. Prevo et al. Small
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started